Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normobaric Hyperoxia in Acute Ischemic Stroke
NCT04681651Phase 2Completed
- Sponsor
- Capital Medical University
- Start
- Apr 2021
- Primary completion
- May 2023
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of oxygen in ischemic stroke (2 arms), sponsored by Capital Medical University. Primary endpoint: Modified Rankin Scale at 90 days. Started Apr 2021; status: completed.
02
Drugs
oxygen
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04681651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04681651.